Cargando…

Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response

BACKGROUND: Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the immune microenvironments of 52 patients with epithelial ovarian cancer, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hua, Gu, Xiangyu, Fan, Rong, Zhu, Qun, Zhong, Sen, Wan, Xirun, Chen, Qian, Zhu, Lan, Feng, Fengzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664484/ https://www.ncbi.nlm.nih.gov/pubmed/37993916 http://dx.doi.org/10.1186/s13048-023-01284-1

Ejemplares similares

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
por: Yang, Hua, et al.
Publicado: (2022)

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
por: Li, Hai Ming, et al.
Publicado: (2015)

Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy
por: Lu, Xiaofan, et al.
Publicado: (2021)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
por: Li, Shuqing, et al.
Publicado: (2020)

Endometrioid Adenocarcinoma with High-Grade Transformation with Serous and Choriocarcinomatous Differentiation - A Case Report
por: Wakahashi, Senn, et al.
Publicado: (2011)

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
por: Tapper, J., et al.
Publicado: (1997)

A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
por: Hammouda, Seifeddine Ben, et al.
Publicado: (2022)

Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma
por: Li, Yimin, et al.
Publicado: (2022)

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015)

Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer
por: Paracchini, Lara, et al.
Publicado: (2022)

Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
por: Fernández-Serra, Antonio, et al.
Publicado: (2023)

Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2011)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
por: Han, Jiheun, et al.
Publicado: (2020)

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
por: Tinker, Anna V., et al.
Publicado: (2022)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
por: Kalinkova, Lenka, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome
por: Salvi, Amrita, et al.
Publicado: (2022)

A Wolf in Sheep’s Clothing: High-Grade Ovarian Endometrioid Carcinoma Masquerading as Pregnancy
por: Almas, Talal, et al.
Publicado: (2020)

Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks
por: Yu, Kun-Hsing, et al.
Publicado: (2020)

Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis
por: Su, Hao, et al.
Publicado: (2023)

Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer
por: Heindl, Andreas, et al.
Publicado: (2016)

High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
por: Gonzalez, Veronica D., et al.
Publicado: (2021)

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
por: Launonen, I.-M., et al.
Publicado: (2022)

Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma
por: Deng, Yingqing, et al.
Publicado: (2022)

High-Grade Endometrioid Stromal Sarcoma of the Ovary: Malignant Transformation of Ovarian Mature Cystic Teratoma
por: Kim, Hyoeun, et al.
Publicado: (2022)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Endometrioid endometrial cancer “recurring” as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
por: Jiang, Wei, et al.
Publicado: (2019)

A Case of Endometrioid Adenocarcinoma Originating from the Serous Surface of the Small Intestine
por: Makihara, Natsuko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5c4nppif5jr4e7fc9jkp3pdqfj